Roche Holding Ltd

ROG

Equity

ISIN CH0012032048 / Valor 1203204

SIX Swiss Exchange (2026-02-20)

CHF 367.80-0.11%

Roche Holding Ltd
UMushroom community rating:

4.36 39 votes No rating yet

NegativeNeutralPositive

About company

Roche Holding Ltd is a global healthcare company known for being one of the largest biotech companies and a leading supplier of in-vitro diagnostics. The company is an innovator in various disease areas such as oncology, neurology, infectious diseases, and ophthalmology. Roche has established partnerships with forward-thinking organizations that share the belief in the power of cutting-edge science and technology to enhance human health.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

24.6%1Y

31.3%3Y

21.3%5Y

Performance

24.7%1Y

20.5%3Y

20.0%5Y

Volatility

326896 M

Market cap (USD)

1,229,452

Daily traded volume (Shares)

253.6 / 250.6

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.36

39 votes

Performance:

3.86

Innovation:

4.23

Society:

3.95

Nature:

3.60

Michelle Meier

Switzerland, 01 Nov 2025

Good

Amin El-Hajj

Switzerland, 01 Nov 2025

Interesting

Mirjam Füchslin

Switzerland, 30 Oct 2025

Roche combines strong financial performance with world-leading innovation in healthcare and diagnostics. The company’s focus on sustainability and patient impact is impressive, though its environmental footprint still leaves room for improvement

EQUITIES OF THE SAME SECTOR

bioMerieux SA